$35.36
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Chiron Real Estate, Inc. engages in the acquisition of purpose-built healthcare facilities and the leasing of those properties to healthcare systems and physician groups. The company is headquartered in Bethesda, Maryland and currently employs 30 full-time employees. The company went IPO on 2012-11-02. The firm acquires healthcare facilities leased to physician groups and regional and national healthcare systems. The firm conducts its business through its limited partnership subsidiary, Chiron Real Estate LP (operating partnership). The company owns 92.0% of the outstanding common operating partnership units (OP Units) of its operating partnership, with an aggregate of 8.0% of the operating partnership owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for OP Units. Its portfolio includes medical office buildings (MOBs), inpatient rehab. facility (IRF), surgical hospitals and others. Its portfolio is located in various areas, including Texas, Florida, Ohio, Arizona, Pennsylvania, Illinois, and Others.
Country

US

CEO

Mr. Mark Decker

IPO date

2012

Employees

30

ISIN

US37954A3032

Key stats

Open

$35.61

Volume

103.94K

Market cap

$476.98M

Prev. close

$35.94

Impl / hst vl

-

Open interest

$0.00

$35.04

Day’s Range

$36.00

$29.05

52W Range

$37.95

Valuation

11
Valuation score
Strongly Overvalued
P/E
-
P/S
-
P/B
-
Current ratio
0.34
Debt / Equity
1.31
ROE
-1.54%
Gross margin
-
Income growth
-89.90%
FCF growth
-38.67

Sep

18

Dividends

The next payment date will be Sep 18, 2026

Div. per Share

$0.32

Div. Yield

0.89%

Payout Ratio

-

Div. Growth YoY

-51.52%

Analysts estimates

Consensus rating
Hold

The average rating from top 6 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$40.55
The top 8 analysts forecasts that 12-month price may increase by 14.68%, with a low of $32.62 and a high of $48.30
$32.62
Low
$40.55
Avg
$48.30
High
Current price

Earnings

Q1 ‘26 revenue
$38.06M
Q1 ‘26 net income
-$749.00K
Revenue
Net income
Previous EPS
-$0.55
Estimate EPS
$0.01
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply